kiaora glp-1 FDA approves Foundayo, an oral alternative to Wegovy and Ozempic The FDA approved a new

Even with IV glutathione, clinical improvements in skin pigmentation are inconsistent and typically modest

Developed by Montmed a proudly Canadian company focused on practical innovation that supports pharmacists and patients

Insurance may or may not cover GLP-1 medications like semaglutide, and even when it does, prior authorization requirements and surprise fees can cause delays and financial stress

CBT and relaxation/biofeedback are most effective in reducing sleep problems in people with fibromyalgia, and all psychological treatments prove equally effective in reducing depression

Call us at 571-244-0052 or visit Bodysculptva.com to schedule your consultation and become a part of our success stories

Innovation is part of our DNA at Evernorth, and we will continue advancing new solutions to make health care better for all. The EnReachRx suite of solutions will be available beginning in June 2025